Correlation Between Pharvaris and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Entrada Therapeutics, you can compare the effects of market volatilities on Pharvaris and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Entrada Therapeutics.
Diversification Opportunities for Pharvaris and Entrada Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pharvaris and Entrada is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Pharvaris i.e., Pharvaris and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between Pharvaris and Entrada Therapeutics
Given the investment horizon of 90 days Pharvaris BV is expected to generate 1.57 times more return on investment than Entrada Therapeutics. However, Pharvaris is 1.57 times more volatile than Entrada Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.16 per unit of risk. If you would invest 1,854 in Pharvaris BV on August 28, 2024 and sell it today you would earn a total of 563.00 from holding Pharvaris BV or generate 30.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharvaris BV vs. Entrada Therapeutics
Performance |
| Timeline |
| Pharvaris BV |
| Entrada Therapeutics |
Pharvaris and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharvaris and Entrada Therapeutics
The main advantage of trading using opposite Pharvaris and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. MediciNova | Pharvaris vs. PepGen |
| Entrada Therapeutics vs. Molecular Partners AG | Entrada Therapeutics vs. Pmv Pharmaceuticals | Entrada Therapeutics vs. Monte Rosa Therapeutics | Entrada Therapeutics vs. Vigil Neuroscience |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |